149 related articles for article (PubMed ID: 10953833)
1. [Helicobacter pylori eradication in gastroduodenal ulcer: good, fine and not expensive].
Piqué JM
Med Clin (Barc); 2000 Jun; 115(1):23-4. PubMed ID: 10953833
[No Abstract] [Full Text] [Related]
2. [Cost-effectiveness analysis of 2 strategies of Helicobacter pylori eradication: results of a prospective and randomized study in primary care].
Gomollón F; Valdepérez J; Garuz R; Fuentes J; Barrera F; Malo J; Tirado M; Simón MA
Med Clin (Barc); 2000 Jun; 115(1):1-6. PubMed ID: 10953829
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of H. pylori eradication.
Roesch W
J Physiol Pharmacol; 1996 Mar; 47(1):71-7. PubMed ID: 8777309
[No Abstract] [Full Text] [Related]
4. [Long term results of treatment by simple surgical closure of perforated gastroduodenal ulcer followed by eradication of Helicobacter pylori].
Tran TT; Quandalle P
Ann Chir; 2006 Oct; 131(8):502-3. PubMed ID: 16716245
[No Abstract] [Full Text] [Related]
5. Treating Helicobacter pylori.
Howden CW; Hunt RH
Arch Intern Med; 1998 Nov; 158(21):2396-8. PubMed ID: 9827792
[No Abstract] [Full Text] [Related]
6. Evaluation of the dyspeptic patient: a cost-utility study.
Ebell MH; Warbasse L; Brenner C
J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan.
Ikeda S; Tamamuro T; Hamashima C; Asaka M
Aliment Pharmacol Ther; 2001 Nov; 15(11):1777-85. PubMed ID: 11683692
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
9. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Romano M; Marmo R; Cuomo A; De Simone T; Mucherino C; Iovene MR; Montella F; Tufano MA; Del Vecchio Blanco C; Nardone G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):273-8. PubMed ID: 15017668
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
Sancar M; Izzettin FV; Apikoglu-Rabus S; Besisik F; Tozun N; Dulger G
Pharm World Sci; 2006 Aug; 28(4):207-14. PubMed ID: 17066247
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
Miehlke S; Kirsch C; Schneider-Brachert W; Haferland C; Neumeyer M; Bästlein E; Papke J; Jacobs E; Vieth M; Stolte M; Lehn N; Bayerdörffer E
Helicobacter; 2003 Aug; 8(4):310-9. PubMed ID: 12950604
[TBL] [Abstract][Full Text] [Related]
14. [Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Domschke W; Dettmer A; Fenner T; Gregor M; Hesse P; Holtmann G; van Husen N; Miederer SE; Schentke KU; Schütz E
Z Gastroenterol; 1995 Oct; 33(10):598-601. PubMed ID: 7502553
[No Abstract] [Full Text] [Related]
15. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
Vakil N; Fennerty MB
Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
[TBL] [Abstract][Full Text] [Related]
16. [Previous treatment with omeprazole and H. pylori: does it diminish the eradication efficacy of the "new" triple therapies of one week's duration?].
Gisbert JP; Boixeda D; Martín de Argila C
Med Clin (Barc); 1998 Nov; 111(18):716. PubMed ID: 9887438
[No Abstract] [Full Text] [Related]
17. [Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
Butorov IV; Osoianu IuP; Butorov SI; Maksimov VV
Klin Med (Mosk); 2005; 83(12):50-3. PubMed ID: 16502725
[TBL] [Abstract][Full Text] [Related]
18. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
19. Cure of Helicobacter pylori: a hidden curse?
Srinivasan R; Minocha A
Am J Gastroenterol; 1997 Dec; 92(12):2313-4. PubMed ID: 9399784
[No Abstract] [Full Text] [Related]
20. Efficacy of different antibiotic regimens for eradication treatment of Helicobacter pylori infection in peptic ulcer disease in Tanzanian patients.
Neuhann HF; Swai B; Carpenter CF; Shao O
Trop Doct; 2003 Oct; 33(4):225-8. PubMed ID: 14620428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
